Levofloxacin
لووفلوکساسین
🦠 Antiinfectives For Systemic UseFluoroquinolone
Market / country: 🇺🇸 USA
Levaquin (US)
🧮 Dose calculator
Community-acquired pneumonia · Regimen source: FDA Levofloxacin · 2.1, Table 1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to levofloxacin or other quinolones. FDA Levofloxacin · 4
- ⚠️ Boxed warning: tendinitis and tendon rupture, peripheral neuropathy, CNS effects and exacerbation of myasthenia gravis; avoid in myasthenia gravis. FDA Levofloxacin · Boxed Warning
Formulations
- 250 mg tablet — tablet 🇺🇸 USA FDA Levofloxacin · 3
- 500 mg tablet — tablet 🇺🇸 USA FDA Levofloxacin · 3
- 750 mg tablet — tablet 🇺🇸 USA FDA Levofloxacin · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Levofloxacin · 8.1
“Risk Summary Published information from case reports, case control studies and observational studies on levofloxacin administered during pregnancy have not identified any drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Levofloxacin · 8.2
“Alternatively, advise a lactating woman that breastfeeding is not recommended during treatment with levofloxacin and for an additional two days (five half-lives) after the last dose [see Use in Specific Populations ( 8.4 ) and Clinical Pharmacology ( 12.3 )].”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Levofloxacin · 8.4
“Inhalational Anthrax (Post-Exposure) Levofloxacin is indicated in pediatric patients 6 months of age and older, for inhalational anthrax (post-exposure).”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Levofloxacin · 8.5
“Caution should be used when prescribing levofloxacin to elderly patients especially those on corticosteroids.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA076710
- DailyMed (FDA label)FDA Levofloxacin
- MedlinePlus (NIH)LevofloxacinLevofloxacin Injection
- WHO ATC/DDDJ01MA12
- Darooyab (Iran)Levofloxacin
🇮🇷 Registered in Iran Darooyab · G-421/Levofloxacin
Dosage forms with Iranian generic codes, per Darooyab.
- 06756 · LEVOFLOXACIN 250MG TAB · قرص لووفلوکساسین ۲۵۰ میلیگرم
- 07183 · LEVOFLOXACIN 500MG TAB · قرص لووفلوکساسین ۵۰۰ میلیگرم
- 16320 · LEVOFLOXACIN 500MG/100ML VIAL · ویال لووفلوکساسین ۵۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 21853 · LEVOFLOXACIN 500MG/20ML INJ · فرآورده تزریقی لووفلوکساسین ۵۰۰ میلیگرم / ۲۰ میلیلیتر
- 18626 · LEVOFLOXACIN 5MG/ML 0.5ML OPH DROP · قطره چشمی لووفلوکساسین ۵ میلیگرم / میلیلیتر ۰٫۵ میلیلیتر
- 12280 · LEVOFLOXACIN 5MG/ML 5ML OPH DROP · قطره چشمی لووفلوکساسین ۵ میلیگرم / میلیلیتر ۵ میلیلیتر
- 19797 · LEVOFLOXACIN 750MG TAB · قرص لووفلوکساسین ۷۵۰ میلیگرم
- 50371 · LEVOFLOXACIN HEMIHYDRATE SOLUTION, DROPS OPHTHALMIC 0.5 % 0.3 mL · قطره چشمی لووفلوکساسین همیهیدرات ۰٫۵ درصد ۰٫۳ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Levofloxacin · 3FDA Levofloxacin · 2.1, Table 1FDA Levofloxacin · 8.4FDA Levofloxacin · 2FDA Levofloxacin · 2.1FDA Levofloxacin · 2.2, Table 2FDA Levofloxacin · 1.8FDA Levofloxacin · 2.2FDA Levofloxacin · 4FDA Levofloxacin · Boxed WarningFDA Levofloxacin · 8.1FDA Levofloxacin · 8.2FDA Levofloxacin · 8.5FDA Levofloxacin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-421/Levofloxacin
- Clinical review⚠ Unverified